Search results for "slas europe 2018"

Uses up to 50% less power and gas, and occupies up to 50% less bench space than other products in its class

Class Leading Technology & Design

Best-in-class sensitivity

Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019

A first-in-man clinical study is planned to start in 2016, with top line results expected end 2017

BMG LABTECH introduces its new product PHERAstar® FSX at SLAS 2016

Meet materials analysis requirements with qualitative and quantitative characterization of all types of conductive and non-conductive unknown samples. The system is available in packages suited for analysis in petroleum, cement, and slags industries or for multi-purpose requirements in analytical laboratories.

As part of Lab Week, Eslam Darwish shares how teamwork, innovation, and rigorous quality control drive excellence in laboratory diagnostics and patient care

Alan Shepherd, Co-Founder of Kbiosystems, reveals the company’s journey and how it is helping to design and equip the laboratories of tomorrow

Class II Type A1, A2

Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019

Rigaku is presenting its XRD and XRF technology for qualitative and quantitative analysis at the 2019 Eastern Analytical Symposium (EAS)

SLAS 2023-TITAN2-Cobin-V4.txt

Recombinantly produced in E. coli, CUTANA™ pAG-MNase for ChIC/CUT&RUN Workflows is a fusion of Proteins A and G to Micrococcal Nuclease. This construct is useful in performing Chromatin Immunocleavage (ChIC) and Cleavage Under Targets and Release Using Nuclease (CUT&RUN). CUTANA™ pAG-MNase contains a C-terminal 6xHis epitope tag. CUTANA™ pAG-MNase for ChIC/CUT&RUN Workflows Formulation: CUTANA™ pAG-MNase is provided as a 20…

Beckman Coulter to present at the European Society for Clinical Cell analysis (ESCCA) 2017